PALIPERIDONE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72658-1253
  • Package NDC 72658-1253-1
  • Application number ANDA218755
  • SPL ID 5f6d19ee-a97d-5cdc-e063-6294a90afbc9
  • SPL set ID de95e29f-a030-4777-a601-874500ab8e91
  • UNII 838F01T721

What the source publishes

Labeler
Eskayef Pharmaceuticals Limited
Active ingredients
PALIPERIDONE
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72658-1253_5f6d19ee-a97d-5cdc-e063-6294a90afbc9
{
  "name": "PALIPERIDONE",
  "splId": "5f6d19ee-a97d-5cdc-e063-6294a90afbc9",
  "labels": [
    {
      "setId": "de95e29f-a030-4777-a601-874500ab8e91",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de95e29f-a030-4777-a601-874500ab8e91",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de95e29f-a030-4777-a601-874500ab8e91"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Eskayef Pharmaceuticals Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1253-1)",
      "package_ndc": "72658-1253-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251002"
    }
  ],
  "productId": "72658-1253_5f6d19ee-a97d-5cdc-e063-6294a90afbc9",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "72658-1253",
  "deaSchedule": null,
  "genericName": "PALIPERIDONE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "PALIPERIDONE",
      "strength": "1.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA218755",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20251002",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175430"
    ],
    "unii": [
      "838F01T721"
    ],
    "spl_set_id": [
      "de95e29f-a030-4777-a601-874500ab8e91"
    ],
    "pharm_class_epc": [
      "Atypical Antipsychotic [EPC]"
    ],
    "manufacturer_name": [
      "Eskayef Pharmaceuticals Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72658-1253_5f6d19ee-a97d-5cdc-e063-6294a90afbc9"